Biography
Sergey Suchkov graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov obtained his Ph.D. He is the PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, Suchkov finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1987 through 1989, Dr. Suchkov was a senior Researcher, Lab of Developmental Immunology, Koltzov Institute of Developmental Biology, USSR Academy of Sciences to deal to developmental immunology. From 1989 through 1995, Dr. Suchkov was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, Dr. Suchkov was being a Chairman of the Department for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. At present, Dr Sergey Suchkov, MD, PhD, is Professor in Immunology, Department of Pathology, School for Pharmacy, I.M. Sechenov First Moscow State Medical University, Dean of the Department (Faculty) of The PPPM Development, and the First Vice-President of the University of World Business, Politics and Law and Secretary General, United Cultural Convention (UCC), Cambridge, UK.
Research Interest
Enzymology, biomarkers, cardiology, Immunology.
Biography
Youhe Gao Professor Beijing Normal University. He received his MD from Peking Union Medical College, his Ph.D from University of Connecticut and postdoctoral training from Beth Israel Deaconess Medical Center Harvard Medical School. He was the professor of Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/ Peking Union Medical College from 2001-2014. His research interests include biomarker discovery in urine proteome, protein interaction and related bioinformatics
Research Interest
Biomarker discovery in urine proteome, Protein interaction and related bioinformatics.
Biography
Lori A. Henderson is a Program Director at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), an institute at the National Institutes of Health (NIH), and has 17 years experience with technical and managerial expertise in several scientific areas: bioengineering, biotechnology, materials science, nanotechnology, enzymology, and biomedical technologies. She currently manages the Nanotechnology and Drug and Gene Delivery programs within the Division of Discovery Science and Technology in the Extramural Division of the NIBIB. She also represents the NIH on the National Science and Technology Council (NSTC) subcommittee on Nanoscale Science, Engineering & Technology (NSET). Her responsibilities at the NIH also include co-managing projects within the Nanomedicine, Interdisciplinary Research, and Regulatory Science programs supported by the NIH Common Fund. These trans-NIH and trans-agency programs include research projects that cut across scientific disciplines and challenges conventional thinking. Prior to the NIH, Dr. Henderson was a Group Leader of the Biomaterials Group within the Polymers Division at the National Institute of Standards and Technology (NIST). Before joining NIST in 2005, Dr. Henderson worked for Novozymes North America, BASF, and Akzo Nobel, where she was a research supervisor, global project leader, and a senior scientist. Dr. Henderson holds a M.S. degree in Macromolecular and Organic Chemistry, and obtained a Ph.D. in Polymer Science from University of Massachusetts, Lowell.
Research Interest
Clinical Trials Branch/Cancer Imaging Program.